The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking discoveries on peripheral immune tolerance, a fundamental aspect of the immune...
Here is a five-step framework that captures the realistic trajectory of how AI will transform healthcare delivery, specifically in infectious diseases. The goals of patient care – today and tomorrow – are to...
Reference: Trieu MC, Bansal A, Svik M, Ljostveit S, Jul-Larsen Á, Cox RJ. Effects of repeated influenza vaccination and infection on durable seroprotection in healthcare workers. npj Vaccines. 2025;10:213. doi:10...
Reference: Zar HJ, Simões EAF, Madhi SA, et al. Clesrovimab for prevention of RSV disease in healthy infants. N Engl J Med. 2025;393(13):1292-1303. Background and Study Rationale Clesrovimab is engineered as a long...
Reference: Zar HJ, Bont LJ, Manzoni P, et al. Clesrovimab in infants and children at increased risk for severe RSV disease. N Engl J Med. 2025;393(13):1343-1345. This interim analysis from the SMART trial represents a...
Reference Pérez Marc G, Vizzotti C, Fell DB, et al. Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during...
Significant progress has been made in preventing respiratory syncytial virus (RSV) infections in infants, with the licensing of at least three prophylactic products. RSV-associated hospitalization rates reach...
Fill Form & Download Overview Haemophilus influenzae is a small Gram-negative coccobacillus colonizing the respiratory tract of humans. The bacterium may cause direct local infections like otitis media, as well as...
As of 30 September 2025 (Asia/Singapore) The list below is a selected summary, not a comprehensive review. Please consult the websites of local Public Health Offices or the local MoH for more complete information and...
Pakistan: Nationwide HPV Rollout Pakistan launched a nationwide human papillomavirus (HPV) vaccination campaign targeting girls aged 9–14. With support from Gavi, UNICEF, and WHO, the program aims to reach 13 million...